www.fdanews.com/articles/195729-fda-clears-bioelectronics-pain-patch-for-musculoskeletal-pain
FDA Clears BioElectronics’ Pain Patch for Musculoskeletal Pain
February 3, 2020
BioElectronics has received an additional 510(k) clearance for its ActiPatch device, a pain relief patch that does not use drugs to deliver treatment.
The patch delivers an electromagnetic pulse to relieve pain. The over-the-counter patch is now cleared for adjunct treatment of musculoskeletal pain, including pain in the back, knees, wrists, hips, elbows and ankles.
The device was given the FDA’s go-ahead in 2017 for OTC treatment of knee osteoarthritis pain and heel pain.